Emphasizes the value of domestic production of key medical devices

FRANKLIN LAKES, NJ, 22 August 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a global leader in medical technology, today celebrated the 75th anniversary of its manufacturing operations in Columbus, Nebraska.and stressed the need and value of domestic production of key medical devices.

The milestone was celebrated at a ceremony that recognized the achievements of the site and its 2,100 employees. In addition to the BD managing directors, Nebraska State and federal officials, including the governor. Jim PillsSenator. Peter RickettsUS Representative. Michael Floodmayor Jim BulkleyThe Columbus Chamber of Commerce and others.

“It is crucial that we support domestic production, such as BD’s plant in Columbus to have a stable domestic supply chain for critical medical products,” said Senator Ricketts. “BD’s commitment to the state Nebraska provides jobs for generations of Nebraskans and plays an important role in protecting our national security and public health. I appreciate BD’s continued support of local businesses and their investment in its Columbus Operations that include: 200 million US dollars of capital investments over the last four years.”

“We are incredibly proud of the people in Columbus And County of Pittsburgh on the great impact they have made over the past 75 years in helping BD become a global leader in the design and manufacture of medical devices,” said Governor Pillen. “From my vantage point, it is clear that BD’s 75 years of success has had a profound impact on the people of Columbus And Nebraska.”

BD Columbus was opened in 1949 with 25,000 square meters and 15 employees who manufactured glass thermometers. Today the company employs 2,100 people in Columbus at three locations and 90,000 square meters. It is one of the largest plants in the BD network and one of only two remaining large-scale syringe manufacturing sites in the United States. The other site is the BD site in Canaan, Connecticut.

“For 75 years Columbus plays a critical role in BD’s global supply chain, producing billions of essential medical products each year to ensure healthcare systems can operate efficiently and care for their patients,” said Eric BorinPresident of BD Medication Delivery Solutions. “BD has consistently risen to the challenge of meeting demand for these critical products. We saw this in the 1950s with the polio vaccine trials, H1N1, COVID-19, and most recently with market disruptions from other foreign suppliers. BD’s U.S. manufacturing teams here in Columbustogether with our website in Canaanhave once again answered the call and increased their domestic syringe production by 50% in the first nine months of 2024 to improve continuity of care for U.S. healthcare providers and their patients.”

The company’s rich history in Columbus began after World War II, when the U.S. government asked the company to diversify the geographic production locations of its goods and help strengthen the resilience of the medical supply chain. This concept continues to this day. Henry Becton And Fairleigh Dickinson Jr. traveled to 30 states before deciding on County of Pittsburgh and the city Columbusafter being impressed by the people’s work ethic and the state’s eagerness to expand its agricultural base.

As part of the celebration, BD honored its longest-serving employees in Columbusincluding two employees who have been with the company for 47 and 48 years and 164 who have been with the company for over 25 years. Learn more about these employees and their stories Here.

About BD
BD is one of the world’s largest global medical technology companies, advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the Frontlines of healthcare by developing innovative technologies, services and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. BD and its more than 70,000 employees are passionate and committed to improving the safety and efficiency of healthcare, enabling laboratory scientists to accurately diagnose disease, and expanding the ability of researchers to develop the next generation of diagnostics and therapies. BD is present in virtually every country and works with organizations around the world to address some of the most challenging global health issues. By working closely with customers, BD can help improve outcomes, reduce costs, increase efficiency, improve safety, and expand access to healthcare. Learn more about BDplease visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.

SOURCE BD (Becton, Dickinson and Company)